Current funding opportunities in cancer research

If you would like us to provide information about a funding opportunity here, please send details to: DundeeCancerCentre@dundee.ac.uk.

Information about the latest generic funding opportunities for research in Medical and Life sciences is available from the Research and Innovation Services website and newsletters.    

 

Cancer Research UK

 

The Innovation Portal

BioKT Fund - Easy Access IP

Grants of up to £20,000 are available for Scottish SMEs in Life Sciences (all areas), Medtech or Food and Health sectors who wish to work on an innovation project with one of the Tayside Research Institutes (University of Dundee, University of Abertay Dundee and the James Hutton Institute).

Deadline: no set deadline

 

Breast Cancer Campaign

Project Grants

Available to fund outstanding breast cancer research.

Deadline: 1 July 2014 

PhD studentships

Available to develop the next generation of breast cancer researchers.

Deadline: 1 July 2014

Tissue Access Scientific fellowship

Available to fund a talented post doctorate researcher utilising material from the Breast Cancer Campaign Tissue Bank.

Deadline: 1 July 2014

Tissue Access Project grant 

Available to fund breast cancer researchers utilising material from the Breast Cancer Campaign Tissue Bank.

Deadline: 1 July 2014

 

Leukaemia & Lymphoma Research

Research projects and programmes

Project Grants are awarded for up to three years usually for the support of one technician, research assistant or post doctoral scientist to carry out a clearly defined project. Specialist Programmes are awarded for up to five years to support a team of researchers to tackle more extensive, long-term goals.

Deadline: 4 July 2014

Career Development funding

LLR supports a range of training an development awards, including Clinical Research Training Fellowships; PhD Studentships ; Senior Career Development Awards, Lectureships/Senior Lectureships and others.

Deadline: 4 July 2014

Clinical Trials

Clinical Trial awards promote phase I/II trials of new chemotherapy and biological entities as a precursor to definitive phase III trials. Funding is also available for trial associated research projects, ie laboratory based research projects which are integral to clinical trials and essential for the analysis of primary and/or secondary end points and clinical outcome.

Deadline: 4 July 2014